Women's Cancer Clinical Roundup

News Articles

(AJMC Managed Markets Network) Nov 24, 2020 - Patients with epithelial ovarian cancer (EOC) who are treated with chemotherapy followed by prolonged poly-ADP-ribose polymerase inhibitors (PARP) may face a the possibility of a heightened risk of severe hematological toxicity, according to a new report.
(Medscape Medical News) Nov 23, 2020 - Women being treated for these cancers have less than ideal adherence to such medications, a new study has found – with just over half reporting taking them exactly as prescribed.
(ESMO Asia 2020) Nov 21, 2020 - The subgroup of East Asian women with hormone receptor (HR)-positive, HER2-negative advanced breast cancer and disease progression on endocrine therapy participating in the phase III MONARCH 2 study continued to show improved survival outcomes compared to placebo plus fulvestrant at approximately 4-year...
(ESMO Asia 2020) Nov 21, 2020 - Pembrolizumab added to chemotherapy provided improved progression-free survival (PFS) in patients with previously untreated locally recurrent inoperable or metastatic triple negative breast cancer (TNBC) that were enrolled from Asia, investigators reported at the ESMO Asia Virtual Congress 2020, held from...
(WHO) Nov 17, 2020 - WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050. Today’s development...
View all breast cancer news
View all cervical cancer news
View all ovarian cancer news

News Commentary

Editor Image
The second immunotherapy approval for triple negative breast cancer came on the...

Featured Breast Cancer Tweets

Julie R. Gralow, MD
jrgralow - Nov 20  It’s official - I am honored to take in the role of @asco’s next CMO! https://t.co/qo03hcaZ6Z

Karen H Lu, MD
karenluMD - Nov 20  Proud of our review article out today @NEJM highlighting #EndometrialCancer. More attention needed, as both inciden… https://t.co/Fgf50kI55j

Deanna G. Teoh, MD, MS, FACOG, FACS
DeannaTeoh - Nov 19  @PCORI @KemiDoll @UWMedicine @uwmnewsroom Congratulations @KemiDoll . What an important study.

Mario M. Leitao, Jr., MD, FACOG, FACS
leitaomd - Nov 18  We MUST do all possible to reduce the burden on women of this disease. Not just vaccine but also better screening o… https://t.co/g2X5bAtbHK